OBX · NASDAQ · Biotechnology

Obsidian Therapeutics Inc. (OBX)

$17.15
At close+0.11 (+0.65%)

Breakdown13F · 13D/G · Form 4

No reliable share count is available for this listing, so stakes are shown as shares, not percentages.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Deep Track Capital, LPStrategic
5.37% of class, as filed13Gfiled Aug 11, 2026
Novo Holdings A/SStrategic
5.10% of class, as filed13Gfiled Aug 10, 2026
RA Capital Management, L.P.Institution
9.70% of class, as filed13Gfiled Aug 10, 2026

13D/13G — an ownership statement filed at 5% or more

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
RA Capital Management, L.P.9.70%13GAug 10, 2026
Deep Track Capital, LP5.37%13GAug 11, 2026
Novo Holdings A/S5.10%13GAug 10, 2026

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.